CIK 0001816590 · Non-accelerated filer<br>Smaller reporting company
COMPASS Pathways plc
Sign in to watch- Ticker
- CMPS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 1-716-676-6461
- Business address
- 3RD FLOOR, 1 ASHLEY ROAD, ALTRINCHAM, CHESIRE, United Kingdom, WA14 2DT
- Former names
- Compass Rx Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-03 | Nath Kabir Chief Executive Officer | Shares withheld for taxes | −5,962 | $11.25 | $67K | 361,028 |
| 2026-05-27 | McQuade Robert Director | Grant or award · Share Option (Right to Buy) | +21,110 | 21,110 | ||
| 2026-05-27 | Tregoning Kathleen Director | Grant or award · Share Option (Right to Buy) | +41,119 | 41,119 | ||
| 2026-05-27 | Karydas Daphne Director | Grant or award · Share Option (Right to Buy) | +21,110 | 21,110 | ||
| 2026-05-27 | Gover Justin D. Director | Grant or award · Share Option (Right to Buy) | +21,110 | 21,110 | ||
| 2026-05-27 | Norton David Y Director | Grant or award · Share Option (Right to Buy) | +21,110 | 21,110 | ||
| 2026-05-27 | Riley Wayne Joseph Director | Grant or award · Share Option (Right to Buy) | +21,110 | 21,110 | ||
| 2026-05-27 | SANTINI GINO Director | Grant or award · Share Option (Right to Buy) | +30,158 | 30,158 | ||
| 2026-05-27 | JONAS JEFFREY M Director | Grant or award · Share Option (Right to Buy) | +21,110 | 21,110 | ||
| 2026-03-26 | Nath Kabir Chief Executive Officer | Grant or award | +175,000 | 366,990 | ||
| 2026-03-26 | Nath Kabir Chief Executive Officer | Grant or award · Share Option (Right to Buy) | +367,815 | 367,815 | ||
| 2026-03-26 | Goodwin Guy Chief Medical Officer | Grant or award · Share Option (Right to Buy) | +55,000 | 55,000 | ||
| 2026-03-26 | Goodwin Guy Chief Medical Officer | Grant or award · Share Option (Right to Buy) | +115,600 | 115,600 | ||
| 2026-03-26 | Loxam Teri Chief Financial Officer | Grant or award | +75,000 | 152,002 | ||
| 2026-03-26 | Loxam Teri Chief Financial Officer | Grant or award · Share Option (Right to Buy) | +157,635 | 157,635 | ||
| 2026-03-11 | Nath Kabir Chief Executive Officer | Shares withheld for taxes | −13,131 | $6.89 | $90K | 191,990 |
| 2026-03-11 | Loxam Teri Chief Financial Officer | Shares withheld for taxes | −1,781 | $6.89 | $12K | 77,002 |
| 2026-03-02 | Loxam Teri Chief Financial Officer | Shares withheld for taxes | −4,467 | $7.02 | $31K | 78,783 |
| 2026-02-02 | Nath Kabir Chief Executive Officer | Shares withheld for taxes | −16,181 | $6.61 | $107K | 205,121 |
| 2025-10-29 | JONAS JEFFREY M Director | Grant or award · Share Option (Right to Buy) | +52,000 | 52,000 |
Page 1 of 12 · 230 trades